Julia E. Colunga-Pedraza
Universidad Autónoma de Nuevo León
38 Papers
24 Citations
Julia E. Colunga-Pedraza is an academic researcher from Universidad Autónoma de Nuevo León. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 5, co-authored 13 publications.
Chat about Author
Papers
Danazol as First-Line Therapy for Myelodysplastic Syndrome.
Perla R. Colunga-Pedraza,Julia E. Colunga-Pedraza,María Alejandra Garza-Ledezma,José Carlos Jaime-Pérez,Olga G. Cantú-Rodríguez,César Homero Gutiérrez-Aguirre,Erick Joel Rendón-Ramírez,Yadith Karina López-García,Rosa Elena Lozano-Morales,Andrés Gómez-De León,Guillermo Sotomayor-Duque,David Gómez-Almaguer +11 more
TL;DR: Danazol as first‐line therapy is an acceptable treatment option with low side effects for patients with MDS who cannot receive ASCT and shows that danazol remains an attractive option because of its low cost and good safety profile in centers with reduced access to novel therapeutic alternatives.
24
Hospitalization rate and costs in acute lymphoblastic leukemia of childhood in a low-income group: Financial impact in Northeast Mexico
José Carlos Jaime-Pérez,Lucía T. Fernández,Raúl Alberto Jiménez-Castillo,Julia E. Colunga-Pedraza,José Ramón Padilla-Medina,Consuelo Mancías-Guerra,David Gómez-Almaguer +6 more
TL;DR: The hospitalization rate and its costs for an open population with ALL in a low‐middle income country and the main and most expensive and prolonged causes of hospitalization for childhood cancer are described.
13
Cord blood banking activities at a university hospital in northeast Mexico: an 8-year experience.
José Carlos Jaime-Pérez,Roberto Monreal-Robles,Julia E. Colunga-Pedraza,Consuelo Mancías-Guerra,Laura Rodriguez-Romo,David Gómez-Almaguer +5 more
TL;DR: This study documented the experience at a public university hospital in northeast Mexico of cord blood bank collection and transplantation activities from developing countries.
11
Outpatient transplantation in the COVID-19 era: a single-center Latin American experience.
Perla R. Colunga-Pedraza,Julia E. Colunga-Pedraza,Jesús D. Meléndez-Flores,Mariana González-Treviño,Eugenia M. Ramos-Dávila,Andrés Gómez-De León,Samantha P. Peña-Lozano,Oscar González-Llano,Olga G. Cantú-Rodríguez,Mónica Bustillos-Muñoz,César Homero Gutiérrez-Aguirre,David Gómez-Almaguer,José Carlos Jaime-Pérez +12 more
Outpatient low toxic regimen with bortezomib in relapsed/refractory acute lymphoblastic leukemia in pediatrics and AYA patients: Single-center Mexican experience.
Julia E. Colunga-Pedraza,Oscar González-Llano,Carlos Eugenio González‐Martinez,David Gómez-Almaguer,José Miguel Yáñez-Reyes,Valentine Jiménez-Antolinez,Perla R. Colunga-Pedraza +6 more
TL;DR: This BZ‐based protocol is effective and safe when administered as an outpatient regimen and feasible in a low resource setting.
5